Todd Lawrence Newman, PA-C

Todd Newman practices at Schweiger Dermatology in Hoboken, New Jersey.

Todd Newman's NPI, 1730398140, was assigned on May 22, 2007. Todd Newman holds New Jersey license 25MP00031200.

Todd Newman's primary practice is Schweiger Dermatology, at 2 Hudson Pl, Hoboken, NJ 07030 in Hudson County. The practice phone is (973) 878-0850.

Todd Newman's primary practice is Schweiger Dermatology in Hoboken, New Jersey. The medical group on file is Schweiger Dermatology Group. Dmand AI also links Todd Newman to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Todd Newman practices. Vendor and product names are available with a free account.

Physician assistant is Todd Newman's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Todd Newman is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Todd Newman's licenses on file in 2 states: New Jersey and New York.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, minor head injury, scalp rash, shingles and skin cyst among the conditions Todd Newman treats.

CMS data shows 376 Medicare services from Todd Newman across 7 procedure codes in 2024, for 168 Medicare patients. Medicare paid $16,279 for them. Every service was in an office.

CMS counts 168 Medicare patients who saw Todd Newman in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 21% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Todd Newman's median patient age at 35, with 45% women.

In 2024, Todd Newman wrote 483 Medicare Part D claims for 180 patients. 95% of them were for generic drugs. CMS names the drug for 385 of them, across 8 drugs with 11 or more claims each, at $7,515 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Todd Newman for performance year 2024, reported as part of a group. Todd Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 343 general payments to Todd Newman from 24 drug and device companies in 2025. Speaker and faculty fees make up the largest share, 65% of the total. Galderma Laboratories, L.P. paid the most, $11,979.